Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 1,484 | 2,150 | 1,192 | 1,115 | 3,963 |
| Cost of Goods | N/A | 20 | 21 | 350 | 1,879 |
| Gross Profit | 1,484 | 2,120 | 24 | 750 | 2,084 |
| Operating Expenses | 13,428 | 10,060 | 21 | 12,850 | 14,698 |
| Operating Income | -11,944 | -7,910 | 1,171 | -11,735 | -11,735 |
| Interest Expense | 0 | 0 | 577 | 0 | 0 |
| Other Income | 635 | -43,880 | -13,702 | 12,850 | 3,478 |
| Pre-tax Income | -11,309 | -51,790 | -13,108 | 1,115 | -8,257 |
| Net Income Continuous | -11,309 | -7,170 | -6,978 | -10,790 | -8,257 |
| Net Income | $-11,309 | $-51,790 | $-13,108 | $-10,790 | $-8,257 |
| EPS Basic Total Ops | -46.80 | -280.76 | -93.59 | -89.99 | -86.39 |
| EPS Basic Continuous Ops | -46.18 | -38.90 | -49.95 | -89.54 | -86.39 |
| EPS Diluted Total Ops | -46.80 | -280.76 | -93.59 | -89.99 | -86.39 |
| EPS Diluted Continuous Ops | -46.18 | -38.90 | -49.95 | -89.54 | -86.39 |
| EBITDA(a) | $-9,956 | $-6,920 | $1,171 | $-11,275 | $-11,016 |